PL2474522T3 - Agomelatyna i jej kompozycje farmaceutyczne - Google Patents

Agomelatyna i jej kompozycje farmaceutyczne

Info

Publication number
PL2474522T3
PL2474522T3 PL10838509T PL10838509T PL2474522T3 PL 2474522 T3 PL2474522 T3 PL 2474522T3 PL 10838509 T PL10838509 T PL 10838509T PL 10838509 T PL10838509 T PL 10838509T PL 2474522 T3 PL2474522 T3 PL 2474522T3
Authority
PL
Poland
Prior art keywords
agomelatine
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
PL10838509T
Other languages
English (en)
Inventor
Jianqiang Zhu
Qingson Tian
Jian Zhao
Original Assignee
Tianjin Taipu Pharmaceutical Science & Tech Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42521392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2474522(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tianjin Taipu Pharmaceutical Science & Tech Development Co Ltd filed Critical Tianjin Taipu Pharmaceutical Science & Tech Development Co Ltd
Publication of PL2474522T3 publication Critical patent/PL2474522T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL10838509T 2009-12-23 2010-12-13 Agomelatyna i jej kompozycje farmaceutyczne PL2474522T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2009102450295A CN101781226B (zh) 2009-12-23 2009-12-23 阿戈美拉汀及其药物组合物
EP10838509.7A EP2474522B1 (en) 2009-12-23 2010-12-13 Agomelatine and pharmaceutical compositions thereof
PCT/CN2010/002026 WO2011075943A1 (zh) 2009-12-23 2010-12-13 阿戈美拉汀及其药物组合物

Publications (1)

Publication Number Publication Date
PL2474522T3 true PL2474522T3 (pl) 2014-08-29

Family

ID=42521392

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10838509T PL2474522T3 (pl) 2009-12-23 2010-12-13 Agomelatyna i jej kompozycje farmaceutyczne

Country Status (9)

Country Link
US (1) US9029420B2 (pl)
EP (1) EP2474522B1 (pl)
JP (1) JP5611344B2 (pl)
CN (1) CN101781226B (pl)
CA (1) CA2776342C (pl)
ES (1) ES2468801T3 (pl)
PL (1) PL2474522T3 (pl)
PT (1) PT2474522E (pl)
WO (1) WO2011075943A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101704763B (zh) * 2009-11-25 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀i型晶体的制备方法
CN101781226B (zh) 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
CN101921205B (zh) * 2010-08-30 2013-11-20 江苏恩华药业股份有限公司 阿戈美拉汀ⅰ晶型的制备方法
CN102452952A (zh) * 2010-11-03 2012-05-16 天津药物研究院 一种高纯度的i型阿戈美拉汀晶体制备方法
CN102690209A (zh) * 2011-03-23 2012-09-26 上海医药工业研究院 阿戈美拉汀的混晶(形式-ⅷ)、其制备方法、应用和包含其的药物组合物
CN102690210A (zh) * 2011-03-23 2012-09-26 上海医药工业研究院 阿戈美拉汀的新晶型ⅶ、其制备方法、应用和包含其的药物组合物
ITMI20111078A1 (it) 2011-06-15 2012-12-16 Laboratorio Chimico Int Spa Procedimento per la preparazione di forme cristalline dell?agomelatina e nuovo polimorfo
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
CN102432490A (zh) * 2011-11-02 2012-05-02 江西施美制药有限公司 一种阿戈美拉汀晶型d及其制备方法
CN103130673B (zh) * 2011-11-28 2017-05-03 重庆医药工业研究院有限责任公司 一种阿戈美拉晶型i的制备方法
CN103360275B (zh) * 2012-03-30 2015-04-22 上海创诺制药有限公司 一种制备阿戈美拉汀ⅰ型晶体的方法
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
CN103655499B (zh) 2013-12-23 2015-07-22 天津泰普药品科技发展有限公司 一种稳定的晶x型阿戈美拉汀片剂及其制备方法
EP3154522A1 (en) * 2014-06-10 2017-04-19 Laboratorio Chimico Internazionale S.p.A. Agomelatine in solution adsorbates and compositions
EP3466923A1 (en) 2017-10-09 2019-04-10 KRKA, d.d., Novo mesto Process for the preparation of agomelatine in crystalline form
EP3466413A1 (en) 2017-10-09 2019-04-10 KRKA, d.d., Novo mesto Pharmaceutical composition containing agomelatine and process for the preparation thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2889522B1 (fr) 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iv de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889523B1 (fr) 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889521B1 (fr) 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2894475B1 (fr) 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
FR2923482B1 (fr) 2007-11-09 2010-01-29 Servier Lab Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2934856B1 (fr) 2008-08-05 2010-08-13 Servier Lab Nouveau procede d'obtention de la forme cristalline v de l'agomelatine
EP2319827A1 (en) 2009-11-09 2011-05-11 Ratiopharm GmbH Process for the production of polymorph form I of agomelatine
CN101781226B (zh) 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
CN101792400B (zh) 2010-03-16 2013-01-30 华东师范大学 一种阿戈美拉汀的合成方法
EP2580183B1 (en) 2010-06-10 2014-07-23 Gador S.A. New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide

Also Published As

Publication number Publication date
CA2776342A1 (en) 2011-06-30
JP2013500276A (ja) 2013-01-07
US20120252901A1 (en) 2012-10-04
ES2468801T3 (es) 2014-06-17
CA2776342C (en) 2014-10-14
PT2474522E (pt) 2014-05-02
CN101781226B (zh) 2012-03-28
US9029420B2 (en) 2015-05-12
JP5611344B2 (ja) 2014-10-22
EP2474522A4 (en) 2013-03-20
WO2011075943A1 (zh) 2011-06-30
CN101781226A (zh) 2010-07-21
EP2474522A1 (en) 2012-07-11
EP2474522B1 (en) 2014-04-09

Similar Documents

Publication Publication Date Title
PT2474522E (pt) Agomelatina e composições farmacêuticas que contêm a mesma
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
IL218016A0 (en) Pharmaceutical compositions comprising bi-1356 and metformin
IL243015B (en) Polycyclic compounds and pharmaceutical preparations containing them
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
ZA201200722B (en) Pharmaceutical composition and administrations thereof
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
ZA201109126B (en) Semi-solid compositions and pharmaceutical products
SG2014012462A (en) Pharmaceutical compositions
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
PT2251006T (pt) Micropartículas e suas composições farmacêuticas
IL221782A (en) Agomalatine Hydrochloride Hydrate and its Pharmaceutical Preparations
ZA201200079B (en) Pharmaceutical compositions and solid forms
IL221783A (en) Agomalatine Hydrobromide Hydrate and its Pharmaceutical Preparations
IL216462A (en) Pharmaceuticals containing nitrile history and uses
GB0902429D0 (en) Compositions and their use
ZA201104882B (en) Pharmaceutical compositions with superior product performance and patient compliance
EP2474306A4 (en) PARTICULATE COMPOSITION AND DRUG COMPOSITION COMPRISING THE SAME
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL219018A (en) Radzolid Pharmaceuticals and Uses
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0909792D0 (en) Composition and uses thereof
GB0908069D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions